Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This study will determine the optimal length of continuation treatment with fluoxetine for
children and adolescents with major depressive disorder, as well as the factors that may
contribute to positive response during acute and continuation treatment.